About: diabetes
Expert: EU research budget needs clear goals to drive diabetes care
The European Union has a critical role to play in optimising the management of diabetes care, by setting clear boundaries and precise objectives through its research funds, an expert has told EURACTIV.
Health budgets, patients pay the cost of fragmented diabetes care: report
The establishment of integrated budgets to tackle diabetes in Europe could bring much better outcomes for patients and simultaneously reduce avoidable costs for health systems of European countries, a new report has found.
Time to focus on EU’s third largest Member State: that of people with diabetes
With everyone’s minds focused on the health, economic and social catastrophe of COVID-19, World Diabetes Day, celebrated last week on 14 November, has not caught the attention of policymakers or the general public. But we neglect ‘Europe’s silent health pandemic’... InfographicPromoted content
Why we need to build online communities for patients with advanced non-melanoma skin cancer?
With the Global Non-Melanoma Skin Cancer (NMSC) Awareness Day nearing on the 13th of June, the European Cancer Patient Coalition (ECPC) launched a NMSC Online Community-Building Toolkit.
Bad eating generates huge costs to society, experts warn
The EU should not lower the guard on non-communicable dietary-related diseases such as obesity and diabetes, as they have a relevant economic impact on citizens' daily life, according to food and nutrition experts.
23 million people fall ill every year because of contaminated foods
Despite tight control networks, foods contaminated with pathogens continue to be regularly sold in the EU and their effects on health can be deadly. Consumer protectors are therefore requesting greater transparency and a rethink of what is considered 'healthy'. EURACTIV Germany reports.
European Commission urged to deliver on new EDCs strategy
MEPs and civil society representatives urged the European Commission on 24 May to act soon on defining a new strategy following the rejection by the European Parliament last autumn of its endocrine disruptor chemicals (EDC) definition.
MEPs step up action to protect terminally ill workers in the EU
A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
Commission sees biotech as ‘integral part’ of EU healthcare
Biotechnology-derived medicinal products are fully part of EU healthcare but there are still many unknowns which call for adequate controls, the European Commission told EURACTIV.
Health matters should supersede European bureaucracy
European red tape should not be an obstacle to effective healthcare. For patients with diseases like sarcoma, waiting means suffering and often avoidable death, writes Marlene Mizzi.
How Italy and France take on rare sarcoma cancers
EU member states are exploring ways to effectively tackle the rising occurrence and complex nature of rare cancers known as sarcomas.
Complex sarcoma cancer needs an overall strategy, report says
The diverse nature of rare cancers like sarcomas poses severe challenges to the medical community and policy-makers who need to seek a holistic approach, according to a report.
Families cannot tackle childhood obesity alone, EU study says
The family environment is not able to overcome childhood obesity without governmental support, a new report has found.
Andriukaitis: ‘Rare cancers present a particular challenge’
The European Commission’s priority when tackling rare cancers such as sarcomas is to ensure European Reference Networks (ERNS) are put in place so that all patients have access to the best expertise available in the EU, Vytenis Andriukaitis told Euractiv.com in an interview.
Rare cancers: A headache for policymakers
The complexity of diagnosing and treating rare forms of cancers like sarcomas can be addressed by a multi-level approach and better coordination among member states, insist experts in the field.
Rare cancers: Cracking the code
The growing number of cases of rare diseases has raised eyebrows in the EU and policymakers are now exploring ways to understand and tackle the complexity of the phenomenon.
Poverty and tobacco carry similar health risks, study finds
People on the bottom rung of the socioeconomic ladder may live two years less on average than those at the top, according to a large-scale study published Wednesday (31 January) in the British journal The Lancet.
Drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science
The world's largest producer of diabetes drugs has invested millions in a new research centre at the University of Oxford despite Brexit and a possible move of the European Medicines Agency from London.
Breast implant victims win payout from German safety body
A French court on Friday ordered German safety certifier TUV to pay €60 million in compensation to 20,000 women who received defective breast implants that the group had approved.
Polish pollution akin to smoking 4,000 cigarettes a year
Air pollution made headlines in Poland this week but the issue was not the only thing to worry Poles, as lack of transparency and corruption in government once again reared their heads. EURACTIV Poland reports.
Germany votes to ease access to medical marijuana
The German Bundestag today (19 January) unanimously passed legislation granting seriously ill patients easier access to medical marijuana. EURACTIV Germany reports.
EU member states still divided over endocrine disruptor regulation
At a meeting of experts yesterday (21 December) the European Commission failed to bridge the gap between member states on setting criteria for endocrine disruptors.
Europe must do more to stamp out lung cancer stigma
Lung cancer is the leading cause of cancer death in the EU and 267,700 people die from it each year across Europe. MEPs and cancer activists call for more to be done to tackle the burden of this disease on the individuals diagnosed, their families and our society.
